The Chromatin Biochemistry lab is delighted to be playing their part in the Rapid Research Response Team that is collaborating with and supporting the Kingdom's healthcare stakeholders to help combat the spread of COVID-19. Our group, in collaboration with Professor Arnab Pain, aims to understand why a large proportion of individuals get infected by the SARS-CoV-2 virus but don’t develop any recognizable disease, whereas some patients progress to life-threatening symptoms. The group is testing whether variations in the epigenome of individuals are key determinants of disease susceptibility. Read more
here